|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Gross profit (loss) | ||||
| Operating expenses: | ||||
| Research and development | ||||
| Selling, general and administrative | ||||
| Loss on retirement of property, plant and equipment | ||||
| Impairment and other | ||||
| Total operating expenses | ||||
| Loss from operations | ||||
| Other income, net: | ||||
| Interest income and other, net | ||||
| Loss on write-off of deferred stock issuance costs | ||||
| Total other income, net | ||||
| Net loss | ||||
| Weighted-average common shares outstanding: | ||||
| Weighted-average common shares outstanding, basic (in shares) | ||||
| Weighted-average common shares outstanding, diluted (in shares) | ||||
| Net loss per share of common stock: | ||||
| Net loss per share of common stock, basic (in dollars per share) | ||||
| Net loss per share of common stock, diluted (in dollars per share) | ||||
Loading...
